Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3034 |
|
| Actual shortage: | 241 (8%) | |
| Anticipated shortage: | 18 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LABETALOL | 100MG | TABLET | Resolved | 2023-12-01 | 2024-01-05 | 212359 |
| APO-KETOTIFEN - SYR 1MG/5ML | 1MG | SYRUP | Actual shortage | 2017-08-13 | 2017-10-05 | 19024 |
| APO-KETOROLAC INJECTABLE | 30MG | SOLUTION | Actual shortage | 2017-08-16 | 2017-10-05 | 19595 |
| APO-KETOROLAC | 10MG | TABLET | Resolved | 2021-04-23 | 2021-05-17 | 137959 |
| APO-KETOROLAC | 10MG | TABLET | Resolved | 2024-03-01 | 2024-04-19 | 221084 |
| APO-KETOROLAC | 10MG | TABLET | Resolved | 2024-03-01 | 2024-04-19 | 221102 |
| APO-KETOCONAZOLE | 200MG | TABLET | Resolved | 2018-01-17 | 2018-07-23 | 36295 |
| APO-KETOCONAZOLE | 200MG | TABLET | Resolved | 2020-08-12 | 2020-09-01 | 122065 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-04-10 | 354 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-02 | 2017-06-27 | 8602 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-25 | 2018-02-23 | 16871 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-25 | 2017-09-25 | 16874 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-05-22 | 2018-08-09 | 50044 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-02-26 | 2020-03-27 | 107199 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 345 |
| APO-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 351 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2017-10-11 | 2017-11-15 | 25287 |
| APO-IRBESARTAN | 150MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 336 |
| APO-IRBESARTAN | 300MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 339 |
| APO-IRBESARTAN | 75MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 342 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |
| APO-SIMVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60790 |
| APO-SIMVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-11-19 | 60793 |
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-SILDENAFIL | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60784 |
| APO-SERTRALINE | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-09-15 | 60781 |
| APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40847 |
| APO-SALVENT TABLETS - 2MG | 2MG | TABLET | Discontinued | 2018-02-23 | 2018-12-28 | 40854 |
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-07-13 | 60758 |
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |
| APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60766 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60769 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60772 |
| APO-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60775 |
| APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2019-02-05 | 60778 |
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
| APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |